Tuberculosis reactivation at ileum following immune checkpoint inhibition with pembrolizumab for metastatic nasopharyngeal carcinoma: a case report

Tuberculosis reactivation at ileum following immune checkpoint inhibition with pembrolizumab for metastatic nasopharyngeal carcinoma: a case report

Abstract Background Tuberculosis (TB) reactivation has been increasingly identified following immune checkpoint inhibitor (ICI) therapy for cancer patients. However there has been no report on TB reactivation in the gastrointestinal tract. In the report, we describe a patient who developed TB ileiti...

Full description

Bibliographic Details
Main Authors: Kin-Sang Lau, Ben Man-Fei Cheung, Ka-On Lam, Sum-Yin Chan, Ka-Ming Lam, Chun-Fai Yeung, Ivan Fan-Ngai Hung, Dora Lai-Wan Kwong, Chi-Chung Tong, To-Wai Leung, Mai-Yee Luk, Anne Wing-Mui Lee, Kwok-Keung Yuen, Victor Ho-Fun Lee
Format: Article
Language:English
Published: BMC 2021-11-01
Series:BMC Infectious Diseases
Subjects:
Nasopharyngeal carcinoma
Immune checkpoint inhibitors
Tuberculosis reactivation
IGRA
Online Access:https://doi.org/10.1186/s12879-021-06845-7

Internet

https://doi.org/10.1186/s12879-021-06845-7

Similar Items